Clinical Relapse versus Treatment failure The case for surveillance for
reappearance of minimal measurable disease in pediatric patients with
higher risk B-ALL.
- Paul Gaynon
, - Linwei Li
Linwei Li
The University of Texas Rio Grande Valley School of Medicine
Author Profile26 Sep 2024Submission Checks Completed 26 Sep 2024Assigned to Editor
26 Sep 2024Submitted to Pediatric Blood & Cancer 27 Sep 2024Review(s) Completed, Editorial Evaluation Pending
02 Oct 2024Reviewer(s) Assigned
09 Oct 2024Editorial Decision: Revise Minor
15 Oct 2024Submission Checks Completed
15 Oct 2024Assigned to Editor
15 Oct 20241st Revision Received
17 Oct 2024Review(s) Completed, Editorial Evaluation Pending
17 Oct 2024Editorial Decision: Accept
